Karina Otręba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Otręba has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Karolina Czupryńska
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
12 shared publications - Joanna Cieszkowska
Uniwersytet Medyczny w Lublinie
7 shared publications - Justyna Składanek
Doctor Anna Gostyńska Wolski Hospital, Marcina Kasprzaka 17, 01-211 Warsaw
7 shared publications - Michał Leśkiewicz
University Clinical Centre of the Medical University of Warsaw, Żwirki i Wigury 63A, 02-091 Warsaw
7 shared publications - Piotr Daniel
National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland
7 shared publications - Barbara Kopczyńska
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
5 shared publications
Latest Publications
- Open Access
- 14 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 26, 55068
Botulinum Toxin Type A: A Therapeutic Alternative for Trigeminal Neuralgia – A Literature-Based Overview
Trigeminal neuralgia (TN) stands as one of the most prevalent forms of craniofacial pain. It commonly targets the areas supplied by the maxillary or mandibular divisions of the trigeminal nerve. Even the slightest stimulation, such as gentle touch can result in severe pain and incapacitation for the patient. The etiology of TN encompasses idiopathic, classic, and secondary classifications. The most common form is the classical type. Carbamazepine and oxcarbazepine are typically the initial pharmacological interventions prescribed for TN, offering relief for many individuals. Considering evidence of varying quality, medications such as lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen, and phenytoin could be viable options, either alone or in combination with carbamazepine or oxcarbazepine, if initial treatments prove ineffective or intolerable. Botulinum toxin type A therapy has shown high efficacy without severe adverse events in alleviating pain in patients with trigeminal neuralgia. This article aims to provide a literature-based overview of trigeminal neuralgia, outlining its unique characteristics, etiology, epidemiology, classification, and management especially using botulinum neurotoxin A.
- 14 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 26, 55068
Open AccessBotulinum Toxin Type A: A Therapeutic Alternative for Trigeminal Neuralgia – A Literature-Based Overview
Trigeminal neuralgia (TN) stands as one of the most prevalent forms of craniofacial pain. It commonly targets the areas supplied by the maxillary or mandibular divisions of the trigeminal nerve. Even the slightest stimulation, such as gentle touch can result in severe pain and incapacitation for the patient. The etiology of TN encompasses idiopathic, classic, and secondary classifications. The most common form is the classical type. Carbamazepine and oxcarbazepine are typically the initial pharmacological interventions prescribed for TN, offering relief for many individuals. Considering evidence of varying quality, medications such as lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen, and phenytoin could be viable options, either alone or in combination with carbamazepine or oxcarbazepine, if initial treatments prove ineffective or intolerable. Botulinum toxin type A therapy has shown high efficacy without severe adverse events in alleviating pain in patients with trigeminal neuralgia. This article aims to provide a literature-based overview of trigeminal neuralgia, outlining its unique characteristics, etiology, epidemiology, classification, and management especially using botulinum neurotoxin A.
- Open Access
- 10 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 24, 55531
Whitlow, felon and paronychia - a clinical review of superficial hand infections
Paronychia, felon and herpetic whitlow are common superficial hand infections. Although having similarities there are many differences between clinical presentation and treatment. Paronychia can present as acute and chronic condition. Treatment options varies from medical to surgical therapy. Formed abscesses may require drainage and possible antibiotic course. Herpetic whitlow is rare manifestation of hand infection with unique treatment options. Chronic infections differs in etiology and clinical presentation and need specialized treatment. Role of noninfectious causes should always be considered, including malignancy if no adequate treatment response is gained. Making correct diagnosis, followed by adequate treatment will prevent huge range of complications. Article reviews common hand infections, presentation, diagnosis and treatment strategies.
- 10 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 24, 55531
Open AccessWhitlow, felon and paronychia - a clinical review of superficial hand infections
Paronychia, felon and herpetic whitlow are common superficial hand infections. Although having similarities there are many differences between clinical presentation and treatment. Paronychia can present as acute and chronic condition. Treatment options varies from medical to surgical therapy. Formed abscesses may require drainage and possible antibiotic course. Herpetic whitlow is rare manifestation of hand infection with unique treatment options. Chronic infections differs in etiology and clinical presentation and need specialized treatment. Role of noninfectious causes should always be considered, including malignancy if no adequate treatment response is gained. Making correct diagnosis, followed by adequate treatment will prevent huge range of complications. Article reviews common hand infections, presentation, diagnosis and treatment strategies.
- Open Access
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55013
Therapeutic potential of curcuminoids in the treatment of selected autoimmune diseases
Introduction The cause of autoimmune diseases is often unknown. Continuous research into the mechanism of these diseases allows us to discover new metabolic pathways, and thus new potential drugs that may become promising therapeutic tools in the future. Alternative methods of treatment are increasingly used when standard therapy does not bring the intended effects. One of the alternative methods of treatment is turmeric contained in Curcuma longa L. Aim of the study The aim of this article was to present the extremely promising potential of turmeric in the treatment of autoimmune diseases. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results In recent years, research on turmeric has accelerated significantly. Due to the insufficient effects of therapy achieved with standard methods of treatment, researchers want to find a new agent to fight serious diseases. Currently available medical literature has confirmed the beneficial effects of turmeric on inflammation in the body. The very mild side effect profile is also worth noting. Conclusions The anti-inflammatory effect obtained after the administration of appropriate doses of turmeric requires further research before it can be registered as one of the preparations for the treatment of autoimmune diseases. However, this topic is very interesting, and the substance itself is very interesting in the context of future disease therapy.
- 13 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 55013
Open AccessTherapeutic potential of curcuminoids in the treatment of selected autoimmune diseases
Introduction The cause of autoimmune diseases is often unknown. Continuous research into the mechanism of these diseases allows us to discover new metabolic pathways, and thus new potential drugs that may become promising therapeutic tools in the future. Alternative methods of treatment are increasingly used when standard therapy does not bring the intended effects. One of the alternative methods of treatment is turmeric contained in Curcuma longa L. Aim of the study The aim of this article was to present the extremely promising potential of turmeric in the treatment of autoimmune diseases. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results In recent years, research on turmeric has accelerated significantly. Due to the insufficient effects of therapy achieved with standard methods of treatment, researchers want to find a new agent to fight serious diseases. Currently available medical literature has confirmed the beneficial effects of turmeric on inflammation in the body. The very mild side effect profile is also worth noting. Conclusions The anti-inflammatory effect obtained after the administration of appropriate doses of turmeric requires further research before it can be registered as one of the preparations for the treatment of autoimmune diseases. However, this topic is very interesting, and the substance itself is very interesting in the context of future disease therapy.
- Open Access
- 10 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 21
The role of collagen in joint disorders: Applications in orthopedics, rheumatology, and sports medicine
Joint diseases are prevalent in orthopedic, rheumatological, and sports medicine fields, significantly impacting patients' quality of life. Collagen, a primary component of connective tissues, has emerged as a therapeutic agent for these conditions. This article explores the applications of collagen in joint diseases, comparing oral and intra-articular administration, evaluating optimal dosages, assessing single versus long-term therapies, discussing side effects, and examining the benefits of hydrolyzed versus non-hydrolyzed collagen. Additionally, explore various sources of collagen and their respective advantages for patient care.
- 10 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 21
Open AccessThe role of collagen in joint disorders: Applications in orthopedics, rheumatology, and sports medicine
Joint diseases are prevalent in orthopedic, rheumatological, and sports medicine fields, significantly impacting patients' quality of life. Collagen, a primary component of connective tissues, has emerged as a therapeutic agent for these conditions. This article explores the applications of collagen in joint diseases, comparing oral and intra-articular administration, evaluating optimal dosages, assessing single versus long-term therapies, discussing side effects, and examining the benefits of hydrolyzed versus non-hydrolyzed collagen. Additionally, explore various sources of collagen and their respective advantages for patient care.
- Open Access
- 10 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 21, 54205
Comparison of Treatment Methods for Carpal Tunnel Syndrome: Surgical vs. Non-Surgical
Introduction Carpal tunnel syndrome (CTS) is a common condition that results from the compression of the median nerve within the carpal tunnel in the wrist. Both surgical and non-surgical treatments are used to manage CTS. While surgery is necessary in some cases, many patients can be treated effectively with conservative methods. This review compares the efficacy of surgical treatment for CTS against various conservative approaches. Aim The study aims to evaluate and compare the outcomes of surgical versus conservative treatments for CTS, focusing on symptom relief, patient outcomes, and long-term prognosis. State of Knowledge The carpal tunnel is a narrow passage in the wrist formed by carpal bones and the flexor retinaculum. Compression of the median nerve within this tunnel leads to CTS, which can be caused by anatomical variations or systemic conditions like diabetes. Symptoms include pain, numbness, and tingling in the hand, which may worsen at night or with repetitive movements. Summary (Conclusions) Surgical treatment, especially decompression, offers superior symptom relief and functional improvement but carries risks of complications. Conservative treatments like wrist immobilization and anti-inflammatory medications are effective for many patients, supporting their use as initial treatment. Further research is needed to optimize CTS management.
- 10 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 21, 54205
Open AccessComparison of Treatment Methods for Carpal Tunnel Syndrome: Surgical vs. Non-Surgical
Introduction Carpal tunnel syndrome (CTS) is a common condition that results from the compression of the median nerve within the carpal tunnel in the wrist. Both surgical and non-surgical treatments are used to manage CTS. While surgery is necessary in some cases, many patients can be treated effectively with conservative methods. This review compares the efficacy of surgical treatment for CTS against various conservative approaches. Aim The study aims to evaluate and compare the outcomes of surgical versus conservative treatments for CTS, focusing on symptom relief, patient outcomes, and long-term prognosis. State of Knowledge The carpal tunnel is a narrow passage in the wrist formed by carpal bones and the flexor retinaculum. Compression of the median nerve within this tunnel leads to CTS, which can be caused by anatomical variations or systemic conditions like diabetes. Symptoms include pain, numbness, and tingling in the hand, which may worsen at night or with repetitive movements. Summary (Conclusions) Surgical treatment, especially decompression, offers superior symptom relief and functional improvement but carries risks of complications. Conservative treatments like wrist immobilization and anti-inflammatory medications are effective for many patients, supporting their use as initial treatment. Further research is needed to optimize CTS management.
- Open Access
- 9 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 54495
Efficacy and Controversies Surrounding Electroconvulsive Therapy for Treatment-Resistant Depression: A Literature Review
Electroconvulsive therapy (ECT) remains a vital treatment option for individuals with treatment-resistant depression (TRD). Despite its historical stigma, controversy, and limited accessibility, ECT has been demonstrated to be beneficial and effective in severe cases of depressive disorders, where medication fails to produce results. It has been utilized since 1938 as a therapeutic technique for various psychiatric disorders, often used as an alternative to chemically induced seizures. The public’s perspectives on ECT hold significance as they can shape attitudes toward patients undergoing this therapy and the discrimination associated with receiving ECT. Additionally, the perspectives of patients who may benefit from ECT and those who are already undergoing treatment are crucial as they can influence treatment decisions and consent processes. This literature review examines the efficacy and controversies surrounding ECT in the management of TRD. Studies assessing the effectiveness of ECT in TRD, along with associated adverse effects and ethical considerations, are reviewed. Additionally, the role of ECT in contemporary psychiatric practice and its comparison with alternative treatments for TRD are discussed. The review highlights the complex interplay between clinical efficacy, safety, patient preferences, and societal perceptions in shaping the utilization of ECT in the treatment of TRD.
- 9 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 54495
Open AccessEfficacy and Controversies Surrounding Electroconvulsive Therapy for Treatment-Resistant Depression: A Literature Review
Electroconvulsive therapy (ECT) remains a vital treatment option for individuals with treatment-resistant depression (TRD). Despite its historical stigma, controversy, and limited accessibility, ECT has been demonstrated to be beneficial and effective in severe cases of depressive disorders, where medication fails to produce results. It has been utilized since 1938 as a therapeutic technique for various psychiatric disorders, often used as an alternative to chemically induced seizures. The public’s perspectives on ECT hold significance as they can shape attitudes toward patients undergoing this therapy and the discrimination associated with receiving ECT. Additionally, the perspectives of patients who may benefit from ECT and those who are already undergoing treatment are crucial as they can influence treatment decisions and consent processes. This literature review examines the efficacy and controversies surrounding ECT in the management of TRD. Studies assessing the effectiveness of ECT in TRD, along with associated adverse effects and ethical considerations, are reviewed. Additionally, the role of ECT in contemporary psychiatric practice and its comparison with alternative treatments for TRD are discussed. The review highlights the complex interplay between clinical efficacy, safety, patient preferences, and societal perceptions in shaping the utilization of ECT in the treatment of TRD.
- Open Access
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51720
Symptoms and prophylaxis of venous thromboembolism in the population of cancer and hospice patients-what is known?
In a group of palliative patients, venous thromboembolism (VTE) is a significant cause of death and reduction in quality of life. Current guidelines and scientific research on thromboprophylaxis most often refer to the population of oncology patients, who differ in many aspects from patients receiving palliative care. Thus, doctors working with patients undergoing palliative treatment have to face many problems related to safety and effectiveness of antithrombotic therapy in this type of care. In the case of chronically ill patients, diagnostic process may be somewhat difficult because the symptoms resulting from the underlying diseases can mask VTE symptoms. The aim of this article is to review the literature on symptoms and thromboprophylaxis in this group of patients. According to the latest guidelines of the American Society of Clinical Oncology (ASCO), it is not recommended to use VTE prophylaxis in outpatient oncology patients routinely, but it should be considered in high-risk patients who received a Khorana score of at least 2 before starting a new chemotherapy cycle. In patients diagnosed with VTE, in long-term prophylaxis lasting at least 6 months, due to greater effectiveness, it is recommended to use low-molecular-weight heparins, edoxaban, rivaroxaban or apixaban instead of vitamin K antagonists, which can be used if the previously mentioned drugs are unavailable. There are some studies which show that thromboprophylaxis may be beneficial for patients in palliative care. On the other hand, another studies’ results suggest that patients won’t gain any benefit from prevention. As our article shows it is very crucial to conduct scientific research on palliative patients and create clear guidelines for prophylaxis for this group of people.
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51720
Open AccessSymptoms and prophylaxis of venous thromboembolism in the population of cancer and hospice patients-what is known?
In a group of palliative patients, venous thromboembolism (VTE) is a significant cause of death and reduction in quality of life. Current guidelines and scientific research on thromboprophylaxis most often refer to the population of oncology patients, who differ in many aspects from patients receiving palliative care. Thus, doctors working with patients undergoing palliative treatment have to face many problems related to safety and effectiveness of antithrombotic therapy in this type of care. In the case of chronically ill patients, diagnostic process may be somewhat difficult because the symptoms resulting from the underlying diseases can mask VTE symptoms. The aim of this article is to review the literature on symptoms and thromboprophylaxis in this group of patients. According to the latest guidelines of the American Society of Clinical Oncology (ASCO), it is not recommended to use VTE prophylaxis in outpatient oncology patients routinely, but it should be considered in high-risk patients who received a Khorana score of at least 2 before starting a new chemotherapy cycle. In patients diagnosed with VTE, in long-term prophylaxis lasting at least 6 months, due to greater effectiveness, it is recommended to use low-molecular-weight heparins, edoxaban, rivaroxaban or apixaban instead of vitamin K antagonists, which can be used if the previously mentioned drugs are unavailable. There are some studies which show that thromboprophylaxis may be beneficial for patients in palliative care. On the other hand, another studies’ results suggest that patients won’t gain any benefit from prevention. As our article shows it is very crucial to conduct scientific research on palliative patients and create clear guidelines for prophylaxis for this group of people.
- Open Access
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51722
Diagnosis and treatment of migraine: an analysis of the latest diagnostic and therapeutic guidelines
Introduction Migraine is a common disease that a large part of the population struggles with. Stressful work and poor eating habits increase the risk of headaches. The basic therapy is lifestyle change, and when this does not bring results, medications are used. The choice of the appropriate preparation depends on the characteristics of the pain and the patient's condition. Knowledge about different treatment methods can improve patients' lives. Aim of the study The aim of the article was to present current guidelines for migraine therapy depending on the individual patient's requirements. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results Many clinical trials have examined the effects of different classes of drugs on migraine headaches. The final effect depends on the dose used, the moment of drug administration, and the patient's age, gender and health condition. Doctors often have to modify therapy within the same group of drugs to find a drug that will work for a given patient. Conclusions Clinical trials have proven the effectiveness of, among others, non-steroidal anti-inflammatory drugs, triptans and botulinum neurotoxin. A clinically significant analgesic effect is sometimes characterized by side effects, therefore careful selection of the preparation and patient observation are important.
- 10 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 74, 51722
Open AccessDiagnosis and treatment of migraine: an analysis of the latest diagnostic and therapeutic guidelines
Introduction Migraine is a common disease that a large part of the population struggles with. Stressful work and poor eating habits increase the risk of headaches. The basic therapy is lifestyle change, and when this does not bring results, medications are used. The choice of the appropriate preparation depends on the characteristics of the pain and the patient's condition. Knowledge about different treatment methods can improve patients' lives. Aim of the study The aim of the article was to present current guidelines for migraine therapy depending on the individual patient's requirements. Materials and methods The article is the result of a review of recent scientific literature using PubMed, Scopus and Google Scholar databases. The literature was reviewed using the keywords. Results Many clinical trials have examined the effects of different classes of drugs on migraine headaches. The final effect depends on the dose used, the moment of drug administration, and the patient's age, gender and health condition. Doctors often have to modify therapy within the same group of drugs to find a drug that will work for a given patient. Conclusions Clinical trials have proven the effectiveness of, among others, non-steroidal anti-inflammatory drugs, triptans and botulinum neurotoxin. A clinically significant analgesic effect is sometimes characterized by side effects, therefore careful selection of the preparation and patient observation are important.
- Open Access
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51718
Precise Classification, and Accurate Diagnosis: Key Elements for Effective Treatment and Management of Headache Disorders
Introduction Tension-type headaches (TTH) are a significant health concern that demands precise diagnostic approaches and effective management strategies. A nuanced understanding of their pathophysiology and diagnostic challenges is not just pivotal, but a responsibility we share, for enhancing patient care. Aim This article aims to explore the complex realm of TTH diagnosis and management, underlining the need for precision in diagnostics and the intricate balance of cost-effectiveness. It also delves into the diverse therapeutic options available for treating TTH, presenting a stimulating challenge for healthcare professionals, researchers, and medical students. State of Knowledge Initial diagnosis involves excluding secondary headaches by identifying red flags indicative of serious underlying conditions. A detailed medical history, complemented by patient-recorded pain diaries, enhances diagnostic accuracy. Ancillary procedures like neuroimaging, despite cost-effectiveness debates, are often preferred by clinicians to mitigate diagnostic risks. Validated tools such as the MIDAS and HIT-6 questionnaires provide valuable insights into headache-related disability. Differential diagnosis among headache types relies on recognizing distinctive clinical features. Summary (Conclusions) Effectively managing TTH necessitates a multifaceted approach, incorporating pharmacological, non-pharmacological, and lifestyle interventions tailored to individual patient needs. Collaborative efforts spanning legal, technological, and research domains are crucial for advancing headache diagnostics and therapeutics. While technological advancements offer promise, interdisciplinary collaboration remains fundamental in optimizing patient care outcomes.
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51718
Open AccessPrecise Classification, and Accurate Diagnosis: Key Elements for Effective Treatment and Management of Headache Disorders
Introduction Tension-type headaches (TTH) are a significant health concern that demands precise diagnostic approaches and effective management strategies. A nuanced understanding of their pathophysiology and diagnostic challenges is not just pivotal, but a responsibility we share, for enhancing patient care. Aim This article aims to explore the complex realm of TTH diagnosis and management, underlining the need for precision in diagnostics and the intricate balance of cost-effectiveness. It also delves into the diverse therapeutic options available for treating TTH, presenting a stimulating challenge for healthcare professionals, researchers, and medical students. State of Knowledge Initial diagnosis involves excluding secondary headaches by identifying red flags indicative of serious underlying conditions. A detailed medical history, complemented by patient-recorded pain diaries, enhances diagnostic accuracy. Ancillary procedures like neuroimaging, despite cost-effectiveness debates, are often preferred by clinicians to mitigate diagnostic risks. Validated tools such as the MIDAS and HIT-6 questionnaires provide valuable insights into headache-related disability. Differential diagnosis among headache types relies on recognizing distinctive clinical features. Summary (Conclusions) Effectively managing TTH necessitates a multifaceted approach, incorporating pharmacological, non-pharmacological, and lifestyle interventions tailored to individual patient needs. Collaborative efforts spanning legal, technological, and research domains are crucial for advancing headache diagnostics and therapeutics. While technological advancements offer promise, interdisciplinary collaboration remains fundamental in optimizing patient care outcomes.
- Open Access
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51716
Intraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN). Consequently, this review aims to provide a comprehensive examination of IPMN, focusing on elucidating its intricate facets including definition, epidemiology, pathogenesis, classification, imaging modalities for diagnosis, analysis of pancreatic cyst fluid, evaluation of malignant potential, and identification of pertinent features. Brief Overview of Current Knowledge: IPMN represents a diagnostic conundrum owing to its variable biological behaviour encompassing both benign and malignant spectra, necessitating meticulous evaluation and risk stratification. Various imaging techniques such as MRI, CT, EUS and abdominal ultrasonography serve pivotal roles in the diagnostic algorithm and risk assessment of IPMN. Additionally, the analysis of pancreatic cyst fluid, incorporating biomarkers and the string sign test, assumes a critical role in discerning mucinous from non-mucinous cysts and gauging malignant potential. Discriminating high-risk stigmata and worrisome features serve as a compass for clinical decision-making regarding the imperative of surgical intervention versus vigilant surveillance. Summary Despite persistent challenges, the ongoing evolution of diagnostic modalities and risk assessment methodologies augur well for refining therapeutic strategies and enhancing clinical outcomes in managing IPMN. This review underscores the imperative of sustained research endeavours in the realm of pancreatic oncology to enrich our comprehension of IPMN pathophysiology and to optimise clinical care paradigms.
- 4 June 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 73, 51716
Open AccessIntraductal Papillary Mucinous Neoplasms (IPMN): Diagnosis, Classification, and Risk Assessment - A Review of Current Medical Knowledge
Introduction In recent years, the widespread utilisation of advanced imaging modalities has led to a surge in the detection rate of pancreatic cystic lesions, particularly intraductal papillary mucinous neoplasms (IPMN). Consequently, this review aims to provide a comprehensive examination of IPMN, focusing on elucidating its intricate facets including definition, epidemiology, pathogenesis, classification, imaging modalities for diagnosis, analysis of pancreatic cyst fluid, evaluation of malignant potential, and identification of pertinent features. Brief Overview of Current Knowledge: IPMN represents a diagnostic conundrum owing to its variable biological behaviour encompassing both benign and malignant spectra, necessitating meticulous evaluation and risk stratification. Various imaging techniques such as MRI, CT, EUS and abdominal ultrasonography serve pivotal roles in the diagnostic algorithm and risk assessment of IPMN. Additionally, the analysis of pancreatic cyst fluid, incorporating biomarkers and the string sign test, assumes a critical role in discerning mucinous from non-mucinous cysts and gauging malignant potential. Discriminating high-risk stigmata and worrisome features serve as a compass for clinical decision-making regarding the imperative of surgical intervention versus vigilant surveillance. Summary Despite persistent challenges, the ongoing evolution of diagnostic modalities and risk assessment methodologies augur well for refining therapeutic strategies and enhancing clinical outcomes in managing IPMN. This review underscores the imperative of sustained research endeavours in the realm of pancreatic oncology to enrich our comprehension of IPMN pathophysiology and to optimise clinical care paradigms.